A Single Ascending Dose Study of PCO371 in Healthy Volunteers
| Status: | Terminated |
|---|---|
| Conditions: | Healthy Studies |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 18 - 45 |
| Updated: | 4/21/2016 |
| Start Date: | June 2015 |
| End Date: | October 2015 |
A Randomized, Double-blind, Single Ascending Oral Dose Study To Evaluate Safety, Tolerability And Pharmacokinetics Of PCO371 In Healthy Volunteers
This is a single-center, placebo-controlled, randomized, double-blind, dose-escalation study
to evaluate safety, tolerability, and PK of a single oral (PO) administration of PCO371 in
healthy adult males.
Caucasian and Japanese subjects will be randomized to receive either PCO371 or placebo.
to evaluate safety, tolerability, and PK of a single oral (PO) administration of PCO371 in
healthy adult males.
Caucasian and Japanese subjects will be randomized to receive either PCO371 or placebo.
Inclusion Criteria:
- Healthy male volunteers aged 18 to 45 years.
- Caucasian(BMI 18-30 mg/kg2) or first generation japanese(BMI 18-25kg/m2)
- Able and willing to abide by the protocol
Exclusion Criteria:
- Evidence of any medical condition that could affect renal, hepatic, or
cardiopulmonary functions.
We found this trial at
1
site
Click here to add this to my saved trials
